MedTrace Logo

Study of HIV, HCV, APS and Phylogenetics for PWID

NCT03447210 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 4301

Last updated 2022-11-21

No results posted yet for this study

Summary

This study will determine whether assisted partner notification services (APS) can identify and link to care, the sexual and needle-sharing partners of HIV-infected and HIV/hepatitis C (HCV) co-infected persons who inject drugs (PWID). It will also define the risk factors for onward HIV and HCV transmission among PWID using viral phylogenetics.

Conditions

Interventions

BEHAVIORAL

Assisted Partner Services

Contact tracing for sexual and drug-sharing partners to notify about exposure to HIV and offer HIV and hepatitis C testing with linkage to care and partner services for those who test positive.

Sponsors & Collaborators

  • National Institute on Drug Abuse (NIDA)

    collaborator NIH

  • Kenyatta National Hospital

    collaborator OTHER_GOV

  • Kenya Ministry of Health

    collaborator OTHER_GOV

  • University of KwaZulu

    collaborator OTHER

  • University of Washington

    lead OTHER

Principal Investigators

  • Joshua Herbeck, PhD · University of Washington

  • Carey Farquhar, MD, MPH · University of Washington

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-26
Primary Completion
2022-02-28
Completion
2022-02-28

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03447210 on ClinicalTrials.gov